Zacks Small Cap Analysis – AZTR: ATR-04 Trial to Dose 1st Affected person Mid-2025 – Model Slux
By John Vandermosten, CFA NYSE:AZTR READ THE FULL AZTR RESEARCH REPORT Azitra, Inc. (NYSE:AZTR) reported first quarter 2025 ends in a Could 13th press launch sharing monetary outcomes and offering a enterprise replace. 12 months so far, the corporate has offered posters at a number of scientific conferences, entered into a purchase order settlement to lift … Read more
